Volume 13, Issue 2, Pages (August 2013)

Slides:



Advertisements
Similar presentations
Constitutively Active β-Catenin Confers Multilineage Differentiation Potential on Lymphoid and Myeloid Progenitors  Yoshihiro Baba, Karla P. Garrett,
Advertisements

Volume 17, Issue 1, Pages (July 2015)
Volume 4, Issue 6, Pages (June 2009)
Canonical Wnt/β-catenin signaling mediates transforming growth factor-β1-driven podocyte injury and proteinuria  Dan Wang, Chunsun Dai, Yingjian Li, Youhua.
Volume 5, Issue 2, Pages (August 2009)
Myung Jin Son, Kevin Woolard, Do-Hyun Nam, Jeongwu Lee, Howard A. Fine 
Francesca Ficara, Mark J. Murphy, Min Lin, Michael L. Cleary 
Tumorigenic Cells Are Common in Mouse MPNSTs but Their Frequency Depends upon Tumor Genotype and Assay Conditions  Johanna Buchstaller, Paul E. McKeever,
Volume 13, Issue 6, Pages (November 2015)
Volume 14, Issue 12, Pages (March 2016)
Volume 20, Issue 3, Pages (July 2017)
Volume 3, Issue 5, Pages (November 2014)
Volume 8, Issue 6, Pages (June 2017)
Volume 18, Issue 5, Pages (May 2003)
Volume 7, Issue 2, Pages (August 2010)
Cytotoxic CD8+ T Cells Stimulate Hematopoietic Progenitors by Promoting Cytokine Release from Bone Marrow Mesenchymal Stromal Cells  Christian M. Schürch,
Volume 13, Issue 3, Pages (September 2013)
Christine V. Ichim, Džana D
Volume 4, Issue 2, Pages (February 2003)
Inhibition of KLF4 by Statins Reverses Adriamycin-Induced Metastasis and Cancer Stemness in Osteosarcoma Cells  Yangling Li, Miao Xian, Bo Yang, Meidan.
Disruption of the BCL11A Erythroid Enhancer Reactivates Fetal Hemoglobin in Erythroid Cells of Patients with β-Thalassemia Major  Nikoletta Psatha, Andreas.
Volume 1, Issue 1, Pages (June 2007)
Volume 4, Issue 2, Pages (February 2015)
Volume 10, Issue 5, Pages (November 2004)
Volume 2, Issue 6, Pages (December 2012)
Kenichi Miharada, Valgardur Sigurdsson, Stefan Karlsson  Cell Reports 
Jungmook Lyu, Vicky Yamamoto, Wange Lu  Developmental Cell 
Volume 43, Issue 2, Pages (August 2015)
Ex Vivo Expansion and In Vivo Self-Renewal of Human Muscle Stem Cells
Ravindra Majeti, Christopher Y. Park, Irving L. Weissman 
Volume 10, Issue 2, Pages (February 2018)
Volume 10, Issue 6, Pages (December 2004)
Rita U. Lukacs, Sanaz Memarzadeh, Hong Wu, Owen N. Witte 
Volume 9, Issue 1, Pages 5-11 (July 2017)
SIRT3 Reverses Aging-Associated Degeneration
Volume 11, Issue 3, Pages (September 2012)
Volume 16, Issue 12, Pages (September 2016)
Masayuki Yamashita, Eriko Nitta, Toshio Suda  Cell Stem Cell 
Volume 6, Issue 3, Pages (March 2010)
Potential Pitfalls of the Mx1-Cre System: Implications for Experimental Modeling of Normal and Malignant Hematopoiesis  Talia Velasco-Hernandez, Petter.
Volume 38, Issue 3, Pages (March 2013)
Volume 15, Issue 4, Pages (October 2001)
Wnt, Activin, and BMP Signaling Regulate Distinct Stages in the Developmental Pathway from Embryonic Stem Cells to Blood  M. Cristina Nostro, Xin Cheng,
Volume 10, Issue 4, Pages (April 2018)
Opposing Effects of TGF-β and IL-15 Cytokines Control the Number of Short-Lived Effector CD8+ T Cells  Shomyseh Sanjabi, Munir M. Mosaheb, Richard A.
Volume 6, Issue 5, Pages (November 2002)
Volume 5, Issue 1, Pages (July 2009)
Volume 5, Issue 5, Pages (November 2015)
Volume 16, Issue 1, Pages (January 2015)
Volume 2, Issue 4, Pages (April 2014)
Volume 2, Issue 1, Pages (January 2008)
Volume 9, Issue 4, Pages (October 2011)
Volume 8, Issue 1, Pages (January 2011)
Volume 3, Issue 6, Pages (December 2014)
Volume 14, Issue 3, Pages (March 2001)
Human hematopoietic stem cell maintenance and myeloid cell development in next-generation humanized mouse models by Trisha R. Sippel, Stefan Radtke, Tayla.
Volume 30, Issue 6, Pages (June 2009)
Volume 8, Issue 4, Pages (April 2017)
Volume 1, Issue 2, Pages (August 2007)
Tobias Maetzig, Jens Ruschmann, Lea Sanchez Milde, Courteney K
Volume 17, Issue 4, Pages (October 2015)
SLAM Family Markers Resolve Functionally Distinct Subpopulations of Hematopoietic Stem Cells and Multipotent Progenitors  Hideyuki Oguro, Lei Ding, Sean J.
Volume 10, Issue 3, Pages (March 2018)
Volume 2, Issue 3, Pages (March 2008)
Volume 13, Issue 6, Pages (November 2015)
Volume 7, Issue 6, Pages (June 2014)
Cellular Heterogeneity in the Mouse Esophagus Implicates the Presence of a Nonquiescent Epithelial Stem Cell Population  Aaron D. DeWard, Julie Cramer,
Wnt Proteins Are Self-Renewal Factors for Mammary Stem Cells and Promote Their Long-Term Expansion in Culture  Yi Arial Zeng, Roel Nusse  Cell Stem Cell 
Volume 13, Issue 2, Pages (August 2013)
Volume 10, Issue 7, Pages (February 2015)
Presentation transcript:

Volume 13, Issue 2, Pages 161-174 (August 2013) CD34− Cells at the Apex of the Human Hematopoietic Stem Cell Hierarchy Have Distinctive Cellular and Molecular Signatures  Fernando Anjos-Afonso, Erin Currie, Hector G. Palmer, Katie E. Foster, David C. Taussig, Dominique Bonnet  Cell Stem Cell  Volume 13, Issue 2, Pages 161-174 (August 2013) DOI: 10.1016/j.stem.2013.05.025 Copyright © 2013 The Authors Terms and Conditions

Cell Stem Cell 2013 13, 161-174DOI: (10.1016/j.stem.2013.05.025) Copyright © 2013 The Authors Terms and Conditions

Figure 1 In Vivo Self-Renewal Capacity of Different CB Populations (A) Approximately 1.2 Lin−CD34−CD38− (−/−; 75,000 cells) and Lin−CD34+CD38− (+/−; 750 cells) SRCs were intravenously (i.v.) injected into separate primary NOD/SCID-β2−/− recipients, and at different weeks after transplant mice were sacrificed and human graft was determined. Calculation of the SRC frequency for each population can be seen in Figure S1. w, weeks. (B) Approximately 5,000 −/−/+ and 750 +/− cells were i.v. injected into primary NSG recipients, and human graft was determined at 12 and 24–26 weeks after transplant. BMs were sampled at 12 weeks for determining human chimerism in mice. eq., equivalent. (C) Secondary transplant with Lin−CD34−CD38−\lo (×12,500, ○25,000, ▵40,000, □60,000, ♢90,000) and Lin−CD34+CD38−\lo (♦1,250, ●2,400, ▴4,800, ▪10,000) cells that were FACS-sorted from primary recipients’ BM originally transplanted with CB −/− (left) or +/− (right) cells. (D) Ex vivo replating potential of engrafted Lin−CD34+CD38−\lo (+/−\lo) cells isolated from primary NSG mice transplanted with CB −/−/+ or +/− cells at 24–26 weeks posttransplant (n = 6). (E) Frequency of +/−\lo populations found in the primary mouse BM at different time points and in the different mouse strains shown in (A) and (B). (F) qRT-PCR for the expression of p16INK4A and p21CIP1 in the +/−\lo populations used for secondary transplant (C) and ex vivo replating assays (D), respectively (n = 5–7). ND, not detected. Median bars are shown; ∗p ≤ 0.03, ∗∗p ≤ 0.003. See also Figure S1. Cell Stem Cell 2013 13, 161-174DOI: (10.1016/j.stem.2013.05.025) Copyright © 2013 The Authors Terms and Conditions

Figure 2 Lin−CD34−CD38−CD93hi HSCs Are Quiescent and Immature (A) Cell-cycle profile of the different CB HSPC populations: −/−/+, +/−, and the four different Lin−CD34+CD38−CD45RA−CD90+or−CD49f+or− populations (see Figure S2) determined by Ki67 and DAPI staining (n = 5). (B) qRT-PCR for different cell cycle regulators genes. Expression values were normalized to −/−/+ as reference population (n = 3-5). (C) Immunocytochemistry of Rbl2 (p130) staining in the indicated CB HSPC populations (scale bars represent 5 μm). (D) Expression of different “HSC fingerprint” genes. −/−/+ cells were used as a reference population (n = 3–5). (E) Immunocytochemistry of Lmo2 and Scl/Tal1 in different CB HSPCs (scale bars represent 5 μm) and in different cell lines as negative\low (–\lo) or positive (+) controls (scale bars represent 10 μm). ± and error bars shown are the SD for the number of experiments performed. In immunocytochemistry stainings, cells were counterstained with DAPI and/or rhodamine phalloidin (Rh-Pha.). In each experiment, 10–15 fields were captured. See also Figure S2. Cell Stem Cell 2013 13, 161-174DOI: (10.1016/j.stem.2013.05.025) Copyright © 2013 The Authors Terms and Conditions

Figure 3 Notch Signaling in Lin−CD34−CD38−CD93hi HSCs (A) Extracellular Notch receptor expression. MFI ratio values (Notch receptors/isotype controls [Iso. Ctrl.]) are shown. Molt4, Raji, and B-CLL cells were used as positive control for Notch1, Notch2, and Notch4 expression, respectively (n = 4). (B) qRT-PCR for the expression of different components of the Notch pathway. −/−/+ population was used as reference (n = 3–5). (C) Intracellular flow-cytometry (FCM) analysis for Hes1 expression. Jurkat cell line was used as a positive control (n = 4). (D) Detection of cleaved Notch1 (N1-IC cleav.), cleaved Notch2 (N2-IC cleav.), and N4-IC in the denoted CB populations, and different cell lines were used as controls (n = 3, each with 10–15 fields captured). Scale bars represent 5 μm. (E) Double-fluorescent immunostaining for Jag1, and Dll4, and αSMA or CD31 on paraffin sections of human placenta beds and umbilical cords (scale bars represent 100 μm). Tissues were counterstained with DAPI. Error bars represent SD. See also Figure S3. Cell Stem Cell 2013 13, 161-174DOI: (10.1016/j.stem.2013.05.025) Copyright © 2013 The Authors Terms and Conditions

Figure 4 Primitive and Quiescent Features of Lin−CD34−CD38−CD93hi HSCs Maintained by Notch Signaling (A) HES1 expression in −/−/+ cells that have been cultured for 5 days on S17 cells expressing the indicated ligand. Cells cultured on S17 were used as a reference (n = 3). (B) CD34 expression on noncultured (NC) −/−/+ and 5-day-cultured cells on S17 cells expressing the indicated ligand (n = 5). Representative FCM plot can be seen in Figure S3F. (C) Primary and secondary cfu assays evaluated with −/−/+ and 5-day-cultured cells on S17 or S17-Dll4 stromal cell lines (n = 3, each in triplicate). (D) qRT-PCR for the expression of different differentiation and “HSC fingerprint” genes as shown in (A). NC −/−/+ cells were used as a reference population (n = 3–5). (E) Cell-cycle analysis of NC −/−/+ and 5-day-cultured cells on S17 cells expressing the indicated ligand (n = 3–5). (F) Expression of different cell-cycle regulator genes as in (A). NC −/−/+ cells were used as a reference population (n = 3–5). (G) Representative FCM histograms for Notch receptor expression on human −/−/+ cells in primary NSG recipients’ BMs that were transplanted with ∼5,000 CB −/−/+ cells 4–6 wks earlier. MFI ratio values are shown (n = 2, each with pool of 2–3 BMs). (H) Immunocytochemistry of Hes1 in NC CB −/−/+ cells and a phenotypically similar population found in primary NSG recipients’ BMs as in (G). n = 2, each with 5–10 fields captured. Scale bars represent 5 μm. (I) ∼5,000 CB −/−/+ cells were transplanted into NSG mice. Five weeks later, mice were treated with vehicle or 4× or 8× with DAPT. Mice were killed and BMs were analyzed at 12 weeks. Median bars are shown. (J) Frequency of human Lin−CD34+CD38−/lo or Lin−CD34+ populations generated in mice treated with vehicle or 4× or 8× with DAPT engrafted with CB −/−/+ cells as described in (I). (K) cfu assay with human cells sorted from mice as described in (I), n = 5. (L) HES1 expression in different +/− subpopulations after 5 days of culture on different ligand-expressing S17 cells. The 90+49f+ population cultured on S17 was used as a reference population (n = 3–5). (M) Primary (left) and secondary (right) cfu colonies assayed with +/− subpopulations after 5 days of culture on S17 or S17-Dll4 stromal cells (n = 5, each in duplicate). (N) Cell-cycle analysis of different +/− subpopulations after 5 days of culture on S17 or S17-Jag1 stromal cells (n = 3). (O) Extracellular Notch receptor expression on different engrafted +/− subpopulations in primary NSG recipients’ BMs at 4–6 weeks posttransplant with 750 CB +/− HSPCs (n = 5). (P) FCM analysis for Hes1 expression in different engrafted +/− subpopulations as in (O) (n = 5). (Q) 750 CB +/− cells were transplanted into NSG mice and 5 weeks later were treated with vehicle or 4× or 8× with DAPT. Engraftment was analyzed at 12 weeks. Median bars are shown. (R) Frequency of human Lin−CD34+CD38−/lo populations generated in mice treated with vehicle or 4× or 8× with DAPT engrafted with CB +/− cells as described in (Q). Error bars represent SD; ∗p ≤ 0.03, ∗∗p ≤ 0.003, ∗∗∗p ≤ 0.0003. See also Figure S4. Cell Stem Cell 2013 13, 161-174DOI: (10.1016/j.stem.2013.05.025) Copyright © 2013 The Authors Terms and Conditions

Figure 5 Quiescent Nature of Lin−CD34−CD38−CD93hi HSCs through the TGF-β/π57κιπ2 Axis (A) Double-fluorescent immunostaining for TGF-β1 and αSMA or CD31 on paraffin sections of human placenta bed and umbilical cords (scale bars represent 100 μm). (B) Expression of different components of the TGF-β pathway in the different CB HSPC populations by qRT-PCR. −/−/+ cells were used as the reference (n = 3–5). (C) Cell-cycle analysis of NC −/−/+ cells and 5-day-cultured cells on S17 stromal alone or with two pulses of TGF-β1 (2.5 ng/ml) or TGF-β1+TGF-β1-blocking antibody (n = 4). (D) qRT-PCR for different cell-cycle regulator genes as in (C). NC −/−/+ cells were used as the reference population (n = 3–5). (E) Representative FCM histogram of p-Smad3 expression in engrafted −/−/+ cells in primary recipients’ BM transplanted with ∼5,000 CB −/−/+ cells 4–6 weeks earlier. MFI ratio is shown (n = 2, each with a pool of 2–3 BMs). (F) Approximately 5,000 CB −/−/+ cells were transplanted into each NGS mouse. Five weeks later, mice were treated either with vehicle or 4× or 8× with SB431542. Engraftment was analyzed at 12 weeks. Median bars are shown. (G) p-Smad3 expression in CB +/− HSPCs and different Lin−CD34+CD38−CD45RA−CD90+or−CD49f+or− fractions (n = 4). (H) Cell-cycle analysis of +/− subfractions cultured for 5 days on S17 stroma alone or with two pulses of TGF-β1 (2.5 ng/ml) or TGF-β1+TGF-β1-blocking antibody (n = 3). (I) 750 CB +/− cells were transplanted into NSG mice, and 5 weeks later mice were treated with vehicle or 4× or 8×x with SB431542. Engraftment was analyzed at 12 weeks. Median bars are shown. (J) p-Smad3 expression in different human +/− subpopulations in primary NSG recipients’ BMs at 4–6 weeks posttransplantation with CB 750 +/− HSPCs. MFI ratio values are shown (n = 5). ± and error bars shown represent SD; ∗p ≤ 0.03, ∗∗p ≤ 0.003. See also Figure S5. Cell Stem Cell 2013 13, 161-174DOI: (10.1016/j.stem.2013.05.025) Copyright © 2013 The Authors Terms and Conditions

Figure 6 Repressed Canonical Wnt Pathway in Lin−CD34−CD38−CD93hi HSCs (A) FCM staining for total β-catenin expression of in the stated CB HSPC subpopulations. Noncultured, NC; stimulated with Wnt3A alone, +; or in combination with LiCl, ++; for 8 hr (n = 6). (B) qRT-PCR for the expression of components of the canonical Wnt pathway in the different CB HSPC populations. +/− cells were used as the reference (n = 4). (C) Primary cfu colonies generated from noncultured (NC); cultured (C); or nucleofected then cultured without any plasmid (Nu.+C), with the construct overexpressing ΔLEF1, or with the control vector (pcDNA3) +/− cells. (D) Secondary colonies derived from +/− HSPCs that were subjected to different conditions as described in (C). (E) Expression of a selected group of genes in +/− HSPCs that have been treated as in (C). Cultured cells were used as the reference (n = 3). (F) Expression of different LEF1 isoforms in NC −/−/+ cells and after culturing in different S17 stromal cell lines for 5 days. Cells cultured on S17 were used as the reference (n = 3). Error bars shown represent SD; ∗p ≤ 0.03. See also Figure S6. Cell Stem Cell 2013 13, 161-174DOI: (10.1016/j.stem.2013.05.025) Copyright © 2013 The Authors Terms and Conditions

Figure 7 Cellular and Molecular Features of BM Lin−CD34−CD38−CD93hi Cells (A) Frequency of −/−/+ cells and different +/− subpopulations found in CB (left), GMPB (middle), and BM (right), n = 5–7. Representative FCM plots of this analysis are shown in Figure S7. (B) Cell-cycle profile of human adult BM −/−/+ and +/− populations determined by Ki67 and DAPI staining (n = 3). (C) qRT-PCR for different cell-cycle regulator genes. The −/−/+ population was used as the reference population (n = 3). (D) Extracellular Notch receptor expression by FCM. MFI ratio values (Notch receptors/isotype controls) are shown. Different cells lines and primary cells were used as controls for the expression of the receptors (n = 3). (E) Expression of different components of the Notch pathway in the denoted BM populations. The −/−/+ population was used as the reference (n = 3). (F) Hes1 expression in BM −/−/+ and +/− populations. MFI values are shown (n = 3). (G) Expression of TGF-β target genes in the denoted BM populations. The −/−/+ population was used as the reference (n = 3). (H) Expression of different components of the Wnt pathway in the denoted BM populations. The +/− population was used as the reference (n = 3). (I) Quantification of the basal canonical Wnt activity by TCF reporter assay in the different BM populations (n = 3). (J) Intracellular FCM analysis for TCF4 expression in the denoted BM populations (n = 3). (K) Graphic representation of the signaling pathways involved in the regulation of −/−/+ HSCs described in this study. Hypothetical Notch ligand-receptor pairing (represented by “?”) involved in the Notch signaling in −/−/+ HSCs. Error bars shown represent SD. Cell Stem Cell 2013 13, 161-174DOI: (10.1016/j.stem.2013.05.025) Copyright © 2013 The Authors Terms and Conditions